Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology

Prostaglandins and Other Lipid Mediators

Volumn 72, Issue 1-2, 2003, Pages 51-71

  Sacerdoti, David ^a   Gatta, Angelo ^a   McGiff, John C ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Arachidonic acid; Cirrhosis; Cytochrome P450; EET; Hepatorenal; HETE; Liver

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); ARACHIDONIC ACID DERIVATIVE; CALCIUM CHANNEL; CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; POTASSIUM CHANNEL; PROADIFEN; PROSTAGLANDIN SYNTHASE; PROTEIN DERIVATIVE; RECOMBINANT PROTEIN; VASOPRESSIN; ARACHIDONIC ACID; HYDROXYICOSATETRAENOIC ACID; ICOSANOID;

BIOLISTIC TRANSFORMATION; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; GLUCAGON RELEASE; GLYCOGENOLYSIS; HORMONAL REGULATION; HUMAN; LIPID METABOLISM; LIVER DISEASE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PROTEIN FUNCTION; REACTION ANALYSIS; REVIEW; STATISTICAL SIGNIFICANCE; STRUCTURE ANALYSIS; VASODILATATION; ANIMAL; CHEMISTRY; LIVER; METABOLISM; PHYSIOLOGY;

ANIMALS; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LIVER; LIVER DISEASES;

EID: 3042640898     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-8823(03)00077-7     Document Type: Article

References (141)

1. Nguyen X., Wang M.H., Reddy K.M., Falck J.R., Schwartzman M.L. Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am. J. Physiol. 276:1999;R1691-R1700
2. Wang M.H., Stec D.E., Balazy M., Mastyugin V., Yang C.S., Roman R.J., et al. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid w-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch. Biochem. Biophys. 336:1996;240-250
3. Imig J.D., Zou A.P., Stec D.E., Harder D.R., Falck J.R., Roman R.J. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol. 270:1996;R217-R227
4. Ito O., Roman R.J. Regulation of 20-hydroxyeicosatetraenoic acid formation in the glomerulus of the rat. Am. J. Physiol. 276:1999;F1749-F1758
5. Harder D.R., Gebremedhin D., Narayanan J., Jefcoat C., Falck J.R., Campbell W.B., et al. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am. J. Physiol. 266:1994;H2098-H2107
6. Gibson G.C. Comparative aspects of the mammalian cytochrome P450IVA gene family. Xenobiotica. 19:1989;1123-1148
7. Lasker J.M., Chen W.B., Wolf I., Bloswick B.P., Wilson P.D., Powell P.K. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J. Biol. Chem. 275:2000;4118-4126
8. Ito O., Alonso-Galicia M., Hopp K.A., Roman R.J. Localization of cytochrome P-450 4A isoforms along the rat nephron. Am. J. Physiol. 274:1998;F395-F404
9. Omata K., Abraham N.G., Schwartzman M.L. Renal cytochrome P450-dependent arachidonic acid metabolism: intrarenal localization and hormonal regulation in spontaneously hypertensive rats. Am. J. Physiol. 262:1992;F591-F599
10. Jacobs E.R., Effros R.M., Falck J.R., Reddy K.M., Campbell W.B., Ahu D. Airway synthesis of 20-hydroxyeicosatetraenoic acid: metabolism by cyclooxygenase to a bronchodilator. Am. J. Physiol. 276:1999;L280-L288
11. Zhu D., Effros R.M., Harder D.R., Roman R.J., Jacobs E.R. Tissue sources of cytochrome P450, 4A and 20-HETE synthesis in rabbit lungs. Am. J. Respir. Cell. Mol. Biol. 19:1998;121-128
12. Harder D.R., Roman R.J., Gebremedhin D.E.K., Birks Lange A.R. A common pathway for regulation of nutritive blood flow to the brain: arterial muscle membrane potential and cytochrome P450 metabolites. Acta Physiol. Scand. 164:1998;527-532
13. Daikh B.E., Lasker J.M., Raucy J.L., Koop D.R. Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P-450 2C8 and 2C9. J. Pharmacol. Exp. Ther. 271:1994;1427-1433
14. Zeldin D.C., Moomaw C.R., Jessee N., Tomer K.B., Beetham J., Hammock B.D. Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch. Biochem. Biophys. 330:1996;87-96
15. Lin J.H.C., Kobari Y., Stermman M.B., Pritchard K.A. Human umbilical vein endothelial cells express P450 2C8 mRNA. Cloning of endothelial P450 epoxygenase. Endothelium. 4:1996;219-229
16. Laethem R.M., Laethem C.L., Koop D.R. Purification and properties of a cytochrome P450 arachidonic acid epoxygenase from rabbit renal cortex. J. Biol. Chem. 267:1992;5552-5559
17. Luo G., Zeldin D.G., Blaisdell J.A., Hodgson E., Goldstein J.A. Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch. Biochem. Biophys. 357:1998;45-57
18. Makita K., Takahashi K., Karara A., Jacobson H.R., Falck J.R., Capdevila J.H. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induced hypertension in rats fed a high salt diet. J. Clin. Invest. 94:1994;2414-2420
19. Knickle L.C., Bend J.R. Dose-dependent, mechanism-based inactivation of cytochrome P450 monooxygenases in vivo by 1-aminobenotriazole in liver, lung, and kidney of untreated, phenobarbitol-treated, and b-napthoflavone-treated guinea pigs. Can. J. Physiol. Pharmacol. 70:1992;1610-1617
20. Laethem R.M., Halpert J.R., Koop D.R. Epoxidation of arachidonic acid as an active-site probe of cytochrome P-450 2B isoforms. Biochem. Biophys. Acta. 1206:1994;42-48
21. Gilday D., Bellward G.D., Sanderson J.T., Janz D.M., Rifkind A.B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic cytochrome P450-dependent arachidonic acid epoxygenation in diverse avian orders: regioisomer selectivity and immunochemical comparison of the TCDD-induced P450s to CYP1A4 and 1A5. Toxicol. Appl. Pharmacol. 150:(1):1998;106-116
22. Ma J., Qu W., Scarborough P.E., Tomer K.B., Moomaw C.R., Maronpot R., et al. Molecular cloning, enzymatic characterization, developmental expression and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J. Biol. Chem. 274:(17):1999;777-788
23. Omata K., Abraham N.G., Escalante B., Schwartzman M.L. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am. J. Physiol. 262:1992;F8-F16
24. Madhun Z., Godthwait D.A., McKay D., Hopfer U., Douglas J.G. An epoxygenase metabolite of arachidonic acid mediates angiotensin II-induced rises in cytosolic calcium in rabbit proximal tubule epithelial cells. J. Clin. Invest. 88:1991;456-461
25. Oyekan A.O., McGiff J.C. Cytochrome P-450-derived eicosanoids participate in the renal functional effects of endothelin-1 in the anesthetized rat. Am. J. Physiol. (Regul. Integr. Comp. Physiol. 43). 274:1998;R52-R61
26. Lin F., Rios A., Falck J.R., Belosludtsev Y., Schwartzman M.L. 20-Hydroxy-eicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am. J. Physiol. 269:1995;F806-F816
27. Nowicki S., Chen S.L., Aizman O., Cheng X.J., Li D., Nowicki C., et al. 20-Hydroxyeicosatetraenoic acid (20-HETE) activates protein kinase C. J. Clin. Invest. 99:1997;1224-1230
28. Silverstein D.M., Barac-Nieto M., Falck J.R., Spitzer A. 20-HETE mediates the effect of parathyroid hormone and protein kinase C on renal phosphate transport. Prostaglandins Leukot. Essent. Fatty Acids. 58:1998;203-213
29. Ribeiro C.M., Dubay G.R., Falck J.R., Mandel L.J. Parathyroid hormone inhibits Na+-K+-ATPase through a cytochrome P-450 pathway. Am. J. Physiol. 266:1994;F497-F505
30. McGiff J.C., Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am. J. Physiol. 277:1999;R607-R623
31. Amlal H., LeGoff C., Vernimmen C., Soleimani M., Paillard M., Bichara M. ANGII controls Na+-K+-(NH4+)-2Cl cotransport via 20-HETE and PKC in medullary thick ascending limb. Am. J. Physiol. 274:1998;C1047-C1056
32. Grider J.S., Falcone J.C., Kilpatrick E.L., Ott C.E., Jackson B.A. P-450 arachidonate metabolites mediate bradykinin-dependent inhibition of NaCl transport in the rat thick ascending limb. Can. J. Physiol. Pharmacol. 75:1997;91-96
33. Iwai N., Inagami T. Isolation of preferential expressed genes in the kidneys of hypertensive rats. Hypertension. 17:1991;161-169
34. Ma Y.H., Schwartzman M.L., Roman R.J. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am. J. Physiol. 267:1994;R579-R589
35. Stec D.E., Deng A.Y., Rapp J.P., Roman R.J. Cytochrome P4504A genotype cosegregates with hypertension in Dahl S rats. Hypertension. 27:1996;564-568
36. Stec D.E., Trolliet M.R., Krieger J.E., Jacob H.J., Roman R.J. Renal cytochrome P4504A activity and salt-sensitivity in spontaneously hypertensive rats. Hypertension. 27:1996;1329-1336
37. Oyekan A.O., Youseff T., Fulton D., Quilley J., McGiff J.C. Renal cytochrome P450 w-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J. Clin. Invest. 104:1999;1131-1137
38. Alonso-Galicia M., Greene A.S., Cowley A.W., Roman R.J. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am. J. Physiol. 283:(1):2002;R60-R68
39. Makita K., Falck J.R., Capdevila J.H. Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system. FASEB J. 10:1996;1456-1463
40. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82:(1):2002;131-185
41. Lapuerta L., Chacos N., Falck J.R., Jacobson H., Capdevila J.H. Renal microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Am. J. Med. Sci. 295:1988;275-279
42. Sundseth S.S., Waxman D.J. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid w-hydroxylases. J. Biol. Chem. 267:1992;3915-3921
43. Imaoka S., Shimojo N., Funae Y. Induction of renal cytochrome P450 in hepatic microsomes of diabetic rats. Biochem Biophys. Res. Commun. 152:1988;680-687
44. Catella F., Lawson J.A., Fitzgerald D.J., FitzGerald G.A. Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc. Natl. Acad. Sci. USA. 87:1990;5893-5897
45. Sacerdoti D., Balazy M., Angeli P., Gatta A., McGiff J.C. Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE. J. Clin. Invest. 100:1997;1264-1270
46. Sacerdoti D., Borsato M., Rigotti P., Amodio P., Angeli P., Ferraresso M., et al. Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporine-induced nephrotoxicity. Adv. Prostaglandins Thromb. Leukot. Res. 21:1991;689-692
47. Nanji A.A., Zhou S., Lamb R.G., Dannenberg A.J., Sadrzadeh S.M., Waxman D.J. Changes in cytochrome P450, 2E1, 2B1, and 4A, and phosholipases A and C in the intragastric feeding rat model for alcoholic liver disease: relationship to dietary fats and pathologic liver injury. Alcohol Clin. Exp. Res. 18:1994;902-908
48. Sacerdoti D., Abraham N.G., McGiff J.C., Schwartzman M.L. Renal cytochrome P450-dependent metabolism of arachidonic acid (AA) in spontaneously hypertensive rats (SHR). Biochem. Pharmacol. 37:(3):1988;521-527
49. Oyekan A.O., McAward K., Cainito J., Rosenfeld L., McGiff J.C. Endothelin-1 and cytochrome P450 arachidonate metabolites interact to promote tissue injury in DOCA/salt hypertension. Am. J. Physiol. 276:1999;R766-R775
50. Sacerdoti D., Escalante B.A., Abraham N.G., McGiff J.C., Levere R.D., Schwartzman M.L. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science. 243:1989;388-390
51. Zou A.P., Ma Y.H., Ortiz de Montellano P.R., Clark J.E., Masters B.S.S., Roman R.J. Effects of 17-ODYA a suicide-substrate inhibitor of P450 fatty acid w-hydroxylase on renal function of rats. J. Pharmacol. Exp. Ther. 268:1994;474-481
52. Alonso-Galicia M., Drummond H.A., Reddy K.M., Falck J.R., Roman R.J. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension. 29:1997;320-325
53. Wang M.H., Brand-Schieber E., Zand B.A., Nguyen X., Falck J.R., Balu N., et al. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J. Pharmacol. Exp. Ther. 284:1998;966-973
54. Capdevila J., Gil L., Orellana M., Marnett L.J., Mason J.I., Yadagiri P., et al. Inhibitors of cytochrome P-450 dependent arachidonic acid metabolism. Arch. Biochem. Biophys. 261:1988;257-263
55. Rodrigues A.D., Gibson G.G., Ioannides C., Parke D.V. Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochem. Pharmacol. 36:1987;4277-4281
56. Alvarez J., Montero M., Garcia-Sancho J. High affinity inhibition of Ca2+-dependent K+ channels by cytochrome P-450 inhibitors. J. Biol. Chem. 267:(11):1992;789-793
57. Villalobos C., Fonteriz R., Lopez M.G., Garcia A.G., Garcia-Sancho J. Inhibition of voltage-gated Ca2+ entry into GH3 and chromaffin cells by imidazole antimycotics and other P450 blockers. FASEB J. 6:1992;2742-2747
58. Khatsenko O.G., Gross S.S., Rifkind A.B., Vane J.R. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. USA. 90:1993;11147-11151
59. Sun C.-W., Alonso-Galicia M., Taheri M.R., Falck J.R., Harder D.R., Roman R.J. Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles. Circ. Res. 83:1998;1069-1079
60. Wang M.H., Wang J., Chang H.H., Zand B.A., Jiang M., Nasjletti A., Laniado-Schwartzman M. Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats. Am. J. Physiol. 285:(2):2003;F295- F302
61. Oyekan A.O., McGiff J.C. Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome P450-derived arachidonate metabolites. Br. J. Pharmacol. 125:1998;1065-1073
62. Wang W., Lu M., Hebert S.C. Cytochrome P-450 metabolites mediate extracellular Ca2+-induced inhibition of apical K+ channels in the TAL. Am. J. Physiol. (Cell Physiol. 40). 271:1996;C103-C111
63. Zou A.-P., Imig J.D., Ortiz de Montellano P.R., Sui Z., Falck J.R., Roman R.J. Effect of P-450 hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am. J. Physiol. (Renal Fluid Electrolyte Physiol. 35). 266:1994;F934-F941
64. Carroll M.A., Garcia M.P., Falck J.R., McGiff J.C. Cyclooxygenase dependency of the renovascular actions of cytochrome P-450-derived arachidonate metabolites. J. Pharmacol. Exp. Ther. 260:1992;104-109
65. Hill E., Fitzpatrick F., Murphy R.C. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. Br. J. Pharmacol. 106:1992;267-274
66. Laniado-Schwartzman M., Falck J.R., Yadagiri P., Escalante B. Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolite. J. Biol. Chem. 264:1989;11658-11662
67. McGiff J.C. Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 31:1991;339-369
68. Escalante B., Erlij D., Falck J.R., McGiff J.C. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science. 251:1991;799-802
69. Escalante B., Erlij D., Falck J.R., McGiff J.C. Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am. J. Physiol. 266:1994;C1775-C1782
70. Sakairi Y., Jacobson H.R., Noland T.D., Capdevila J.H., Falck J.R., Breyer M.D. 56-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis. Am. J. Physiol. 268:1995;F931-F939
71. Pratt P.F., Falck J.R., Komandla M.R., Kurian J.B., Campbell W.B. 20-HETE relaxes bovine coronary arteries through the release of prostacyclin. Hypertension. 31:1998;37-241
72. Carroll M.A., Balazy M., Margiotta P., Huang D.-D., Falck J.R., McGiff J.C. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am. J. Physiol. (Regul Integr. Comp. Physiol. 40). 271:1996;R863-R869
73. Carroll M.A., Balazy M., Margiotta P., Falck J.R., McGiff J.C. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J. Biol. Chem. 268:1993;12260-12266
74. Ellis E.F., Police R.J., Yancey L., McKinney J.S., Amruthesh S.C. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am. J. Physiol. (Heart Circ. Physiol. 28). 259:1990;H1171-H1177
75. Gebremedhin D., Lange A.R., Narayanan J., Harder D.R. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current. J. Physiol. 507:1998;771-781
76. Zou A.-P., Fleming J.T., Falck J.R., Jacobs E.R., Gebremedhin D., Harder D.R., et al. 20-HETE is an endogenous inhibitor of the large-conductance Ca2+-activated K+ channel in renal arterioles. Am. J. Physiol. 270:1996;R226-R237
77. Lange A., Gebremedhin D., Narayanan J., Harder D.R. 20- Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J. Biol. Chem. 272:1997;345-352
78. Sun C.W., Falck J.R., Harder D.R., Roman R.J. Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension. 33:1999;414-418
79. Mutahalif M.M., Benter I.F., Karzoun N., Fatima S., Harper J., Uddin M.R., et al. 20-HETE mediates calcium/calmodulin dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA. 95:(12):1998;701-706
80. Uddin M.R., Muthalif M.M., Karzoun N.A., Benter I.F., Malik K.U. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension. 31:1998;242-247
81. Imig J.D., Zou A.P., Ortiz de Montellano P.R., Sui Z., Roman R.J. Inhibitors of cytochrome P-450 alter afferent arteriolar responses to elevations in pressure. Am. J. Physiol. 266:1994;H1879-H1885
82. Alonso-Galicia M., Sun C.W., Falck J.R., Harder D.R., Roman R.J. Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. Am. J. Physiol. 275:1998;F370-F378
83. Schwartzman M., Ferreri N.R., Carroll M.A., Songu-Mize E., McGiff J.C. Renal cytochrome P450-related arachidonate metabolite inhibits Na+K+ ATPase. Nature. 314:1985;620-623
84. Zhang Y.B., Magyar C.E., Holstein-Rathlou N.H., McDonough A.A. The cytochrome P-450 inhibitor cobalt chloride prevents inhibition of renal Na+, K+-ATPase and redistribution of apical NHE-3 during acute hypertension. J. Am. Soc. Nephrol. 9:1998;531-537
85. Carroll M.A., Ferreri N.R., Escalante B.A., Oyekan A.O., McGiff J.C. Cytochrome P450 arachidonic acid metabolites modulate renal tubular function. Adv. Exp. Med. Biol. 525:2003;67-69
86. Lu M., Wang X., Wang W. Nitric oxide increases the activity of the apical 70 pS K+ channel in TAL of rat kidney. Am. J. Physiol. 274:1998;F946-F950
87. Ito O., Roman R.J. Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats. Hypertension. 33:1999;419-423
88. Liu H.J., Mount D.B., Nasjletti A., Wang W. Carbon monoxide stimulates the apical 70 pS K+ channel of the rat thick ascending limb. J. Clin. Invest. 103:1999;963-970
89. Imig J.D., Navar L.G., Roman R.J., Reddy R.J., Falck J.R. Actions of epoxygenase metabolites on the preglomerular vasculature. J. Am. Soc. Nephrol. 7:1996;2364-2370
90. Zou A.P., Fleming J.T., Falck J.R., Jacobs E.R., Gebremedhin D., Harder D.R., et al. Stereospecific effects of epoxyeicosatrienoic acids on vascular tone and K+-channel activity. Am. J. Physiol. 270:1996;F822-F832
91. Gebremedhin D., Ma Y.H., Roman R.J., Van Rollins M., Falck J.R., Harder D.R. Cellular mechanism of cerebral epoxyeicosatrienoic acids (EETs) on cat cerebral arterial smooth muscle. Am. J. Physiol. 263:1992;H519-H525
92. Rosolowsky M., Campbell W.B. Role of PGI2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid. Am. J. Physiol. 264:1993;H327-H335
93. Gebremedhin D., Harder D.R., Pratt P.F., Campbell W.B. Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J. Vasc. Res. 35:1998;274-284
94. Alkayed N.J., Birks E.K., Hudetz A.G., Roman R.J., Henderson L., Harder D.R. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am. J. Physiol. 271:1996;H1541-H1546
95. Wu S., Chen W., Murphy E., Gabel S., Tomer K.B., Foley J., et al. Molecular cloning, expression, and functional significance of a cytochrome P-450 highly expressed in rat heart myocytes. J. Biol. Chem. 272:(12):1997;551-559
96. Zeldin D.C., Plitman J.D., Kobayashi J., Miller R.F., Snapper J.R., Falck J.R., et al. The rabbit pulmonary CYP arachidonic acid metabolic pathway: characterization and significance. J. Clin. Invest. 95:1995;2150-2160
97. Li P.L., Campbell W.B. Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ. Res. 80:1997;877-884
98. Imig J.D., Inscho E.W., Deichmann P.C., Reddy K.M., Falck J.R. Afferent arteriolar vasodilation to the sulfonamide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A. Hypertension. 33:1999;408-413
99. Campbell W.B., Gebremedhin D., Pratt P.F., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78:1996;415-423
100. Hecker M., Bara A.T., Bauersachs J., Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. 481:1994;407-414
101. Petersson J., Zygmunt P.M., Jonsson P., Hogestatt E.D. Characterization of endothelium-dependent relaxation in guinea pig basilar artery: effect of hypoxia and role of cytochrome P450 mono-oxygenase. J. Vasc. Res. 35:1998;285-294
102. Vanheel B., Van de Voorde J. Evidence against the involvement of cytochrome P450 metabolites in endothelium-dependent hyperpolarization of the rat main mesenteric artery. J. Physiol. 501:1997;331-341
103. Alkayed N.J., Narayanan J., Gebremedhin D., Medhora M., Roman R.J., Harder D.R. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke. 27:1996;971-979
104. Harris R.C., Homma T., Jacobson H.R., Capdevila J. Epoxyeicosatrienoic acids activate Na+/H+ exchange and are mitogenic in cultured rat glomerular mesangial cells. J. Cell. Physiol. 144:1990;429-437
105. Dumoulin M., Salvail D., Gaudreault S.B., Cadieux A., Rousseau E. Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels. Am. J. Physiol. 275:1998;L423-L431
106. Falck J.R., Manna S., Moltz J., Chacos N., Capdevila J. Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets. Biochem. Biophys. Res. Commun. 114:(2):1983;743-749
107. Zeldin D.C., Foley J., Boyle J.E., Moomaw C.R., Tomer K.B., Parker C., et al. Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology. 138:(3):1997;1338- 1346
108. Node K., Huo Y., Ruan X., Yang B., Spiecker M., Ley K., et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 285:(5431):1999;1276-1279
109. Karara A., Dishman E., Falck J.R., Capdevila J.H. Endogenous epoxyeicosatrienoyl-phospholipids. J. Biol. Chem. 266:1991;7561-7569
110. Carroll M.A., Balazy M., Huang D.D., Rybalova S., Falck J.R., McGiff J.C. Cytochrome P450-derived renal HETEs: storage and release. Kidney Int. 51:1997;1696-1702
111. Zhu Y., Brand Schieber E., McGiff J.C., Balazy M. Identification of arachidonate P-450 metabolites in human platelet phospholipids. Hypertension. 25:1995;854-859
112. Gordon J.A., Spector A.A. Effects of 12-HETE on renal tubular epithelial cells. Am. J. Physiol. (Cell Physiol. 22). 253:1987;C277-C285
113. Wong P.Y.-K., Lai P.-S., Shen S.-Y., Belosludtsev Y.Y., Falck J.R. Post-receptor signal transduction and regulation of 14(R)15(S)- epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells. J. Lipid Mediat. Cell Signal. 16:1997;155-169
114. Quilley J, Bell-Quilley JP, McGiff JC. Eicosanoids and hypertension. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven; 1995. p. 963-82.
115. Campbell W.B., Deeter C., Gauthier K.M., Ingraham R.H., Falck J.R., Li P.L. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. Am. J. Physiol. 282:(5):2002;H1656-H1664
116. Dumoulin M., Salvail D., Gaudreault S.B., Cadieux A., Rousseau E. Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels. Am. J. Physiol. 275:1998;L423-L431
117. Gonzalez F.J., Lee Y.H. Constitutive expression of hepatic cytochrome P450 genes. FASEB J. 10:(10):1996;1112-1117
118. Capdevila J., Chacos N., Werringloer J., Prough R.A., Estabrook R.W. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc. Natl. Acad. Sci. U. S. A. 78:(9):1981;5362-5366
119. Capdevila J., Marnett L.J., Chacos N., Prough R.A., Estabrook R.W. Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids. Proc. Natl. Acad. Sci. USA. 79:1982;767-770
120. Falck J.R., Lumin S., Blair I., Dishman E., Martin M.V., Waxman D.J., et al. Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetarenoic acids. J. Biol. Chem. 265:1990;10244-10249
121. Oliw E.H., Oates J.A. Oxygenation of arachidonic acid by hepatic microsomes of the rabbit. Mechanism of biosynthesis of two vicinal dihydroxyeicosatrienoic acids. Biochim. Biophys. Acta. 666:(3):1981;327-340
122. Capdevila J., Pramanik B., Napoli J.L., Manna S., Falck J.R. Arachidonic acid epoxidation: epoxyeicosatrienoic acids are endogenous constituents of rat liver. Arch. Biochem. Biophys. 231:(2):1984;511-517
123. Karara A., Dishman E., Blair I., Falck J.R., Capdevila J.H. Endogenous epoxyeicosatrienoic acids cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase. J. Biol. Chem. 264:(33):1989;19822-19827
124. Rifkind A.B., Lee C., Chang T.K., Waxman D.J. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch. Biochem. Biophys. 320:(2):1995;380-389
125. Laethem R.M., Balazy M., Falck J.R., Laethem C.L., Koop D.R. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J. Biol. Chem. 268:(17):1993;12912-12918
126. Yoshida S., Hirai A., Tamura Y., Yoshida S. Possible involvement of arachidonic acid metabolites of cytochrome P450 monooxygenase pathway in vasopressin-stimulated glycogenolysis in isolated rat hepatocytes. Arch. Biochem. Biophys. 280:(2):1990;346-351
127. Qu W., Rippe R.A., Ma J., Scarborough P., Biagini C., Fiedorek F.T., et al. Nutritional status modulates rat liver cytochrome P450 arachidonic acid metabolism. Mol. Pharmacol. 54:(3):1998;504-513
128. Capdevila J.H., Falck J.R. Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases. Prostaglandins Other Lipid Mediat. 68-69:2002;325-344
129. Sacerdoti D., Carroll M., Gatta A., Mcgiff J.C., Oyekan A. Role of cytochrome P450-dependent arachidonic acid metabolites in regulation of portal resistance. J. Hepatol. 30:1999;66
130. Karara A., Wei S., Spady D., Swift L., Capdevila J.H., Falck J.R. Arachidonic acid epoxygenase: structural characterization and quantification of epoxyeicosatrienoates in plasma. Biochem. Biophys. Res. Commun. 182:(3):1992;1320-1325
131. George J., Murray M., Byth K., Farrel C. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology. 21:1995;120-128
132. Solangi K., Sacerdoti D., Goodman A.I., Schwartzman M.L., Abraham N.G., Levere R.D. Differential effects of partial hepatectomy on hepatic and renal heme and cytochrome P450 metabolism. Am. J. Med. Sci. 296:(6):1988;387-391
133. Edwards G., Zygmunt P.M., Hogestatt E.D., Weston A.H. Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein. Br. J. Pharmacol. 119:(4):1996;691-701
134. Sacerdoti D., Bolognesi M., Gatta A., McGiff J.C., Oyekan A. CYP450-dependent epoxyeicosatrienoic acids (EETs) may participate in the pathophysiology of portal hypertension by differentially modulating portal and mesenteric arterial resistance in cirrhotic rats. Hepatology. 30:1999;237A
135. Chu Z.M., Croft K.D., Kingsbury D.A., Falck J.R., Reddy K.M., Beilin L.J. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo. Clin. Sci. 98:2000;277-282
136. Earley S., Pastuszyn A., Walker B.R. Cytochrome P450 epoxygenase products contribute to attenuated vasoconstrictor responsiveness following chronic hypoxia. Am. J. Physiol. Heart. Circ. Physiol. 285:2003;H127-H136
137. Sacerdoti D., Bolognesi M., Gatta A., McGiff J.C., Oyekan A. CYP-dependent epoxyeicosatrienoic acids (EETs) may participate in the pathophysiology of portal hypertension by differentially modulating portal and mesenteric arterial resistance in cirrhotic rats. Hepatology. 30:1999;237A
138. Sacerdoti D., Escalante B.A., Schwartzman M.L., Abraham N.G., Gatta A., McGiff J.C. Renal cytochrome P-450-dependent metabolism of arachidonic acid in cirrhotic rats. J. Hepatol. 12:1991;230-235
139. Arroyo V., Gines P., Rimola A., Gaya J. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. Am. J. Med. 81:1986;104-122
140. Moore K.P., Taylor G.W., Maltby N.H., Siegers D., Fuller R.W., Dollery C.T. Increased production od cysteinyl leukotrienes in hepatorenal syndrome. J. Hepatol. 11:1990;263-271
141. Prakash C., Zhang J.Y., Falck J.R., Chauhan K., Blair I.A. 20-Hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine. Biochem. Biophys. Res. Commun. 185:(2):1992;728-733